相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FGFR4 Promotes Stroma-Induced Epithelial-to-Mesenchymal Transition in Colorectal Cancer
Rui Liu et al.
CANCER RESEARCH (2013)
Identification of Galanin and Its Receptor GalR1 as Novel Determinants of Resistance to Chemotherapy and Potential Biomarkers in Colorectal Cancer
Leanne Stevenson et al.
CLINICAL CANCER RESEARCH (2012)
FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma
Lisa E. S. Crose et al.
CLINICAL CANCER RESEARCH (2012)
FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior
Athina-Myrto Chioni et al.
JOURNAL OF CELL BIOLOGY (2012)
A Systems Biology Approach Identifies SART1 as a Novel Determinant of Both 5-Fluorouracil and SN38 Drug Resistance in Colorectal Cancer
Wendy L. Allen et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models
Dorothy M. French et al.
PLOS ONE (2012)
The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue
O. Oladipo et al.
BRITISH JOURNAL OF CANCER (2011)
Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase
Vito Guagnano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis
Toru Tateno et al.
PLOS GENETICS (2011)
FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation
Xinle Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells
A. Roidl et al.
ONCOGENE (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
Resistance to Chemotherapy Is Associated with Fibroblast Growth Factor Receptor 4 Up-Regulation
Andreas Roidl et al.
CLINICAL CANCER RESEARCH (2009)
Nuclear Expression of Epidermal Growth Factor Receptor is a Novel Prognostic Value in Patients With Ovarian Cancer
Weiya Xia et al.
MOLECULAR CARCINOGENESIS (2009)
Combined inhibition of FLIP and XIAP induces Bax-independent apoptosis in type II colorectal cancer cells
T. R. Wilson et al.
ONCOGENE (2009)
Nuclear EGFR contributes to acquired resistance to cetuximab
C. Li et al.
ONCOGENE (2009)
Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice
Xinle Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models
Lr Desnoyers et al.
ONCOGENE (2008)
Liver-specific activities of FGF19 require Klotho beta
Benjamin C. Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer
K. Sahadevan et al.
JOURNAL OF PATHOLOGY (2007)
c-FLIP: A key regulator of colorectal cancer cell death
Timothy R. Wilson et al.
CANCER RESEARCH (2007)
The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma
Valeria Cristina da Costa Andrade et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2007)
FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients
S. Streit et al.
BRITISH JOURNAL OF CANCER (2006)
Receptor specificity of the fibroblast growth factor family - The complete mammalian FGF family
Xiuqin Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
c-FLIP inhibits chemotherapy-induced colorectal cancer cell death
DB Longley et al.
ONCOGENE (2006)
Molecular mechanisms of drug resistance
DB Longley et al.
JOURNAL OF PATHOLOGY (2005)
Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan
J Boyer et al.
CLINICAL CANCER RESEARCH (2004)
The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression
JH Wang et al.
CLINICAL CANCER RESEARCH (2004)
FGFR4 overexpression in pancreatic cancer is mediated by an intronic enhancer activated by HNF1α
RNH Shah et al.
ONCOGENE (2002)
A mouse model of hepatocellular carcinoma - Ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice
K Nicholes et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
被撤回的出版物: Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis (Retracted article. See vol. 125, pg. 3303, 2015)
S Ezzat et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
KC Hart et al.
ONCOGENE (2000)
FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors
SH Ong et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
